Ionis Pharmaceuticals Inc. Daily Stock Analysis

Daily Stock Analysis, IONS, Ionis Pharmaceuticals Inc, priceseries

Ionis Pharmaceuticals Inc. Daily Stock Analysis
Stock Information
Open
32.21
Close
32.17
High
32.85
Low
31.71
Previous Close
32.30
Daily Price Gain
-0.13
YTD High
34.55
YTD High Date
Feb 10, 2022
YTD Low
28.25
YTD Low Date
Jan 31, 2022
YTD Price Change
-0.43
YTD Gain
-1.32%
52 Week High
55.96
52 Week High Date
Mar 22, 2021
52 Week Low
25.04
52 Week Low Date
Dec 2, 2021
52 Week Price Change
-19.02
52 Week Gain
-37.16%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Apr 12. 2017
39.35
May 8. 2017
46.28
17 Trading Days
17.61%
Link
LONG
Aug 30. 2017
50.99
Sep 20. 2017
54.20
14 Trading Days
6.30%
Link
LONG
Oct 4. 2017
54.31
Oct 24. 2017
58.14
14 Trading Days
7.05%
Link
LONG
Aug 8. 2018
45.57
Aug 24. 2018
49.95
12 Trading Days
9.62%
Link
LONG
Sep 14. 2018
46.00
Oct 1. 2018
50.33
11 Trading Days
9.42%
Link
LONG
Oct 30. 2018
49.06
Nov 9. 2018
51.59
8 Trading Days
5.16%
Link
LONG
Jan 4. 2019
54.33
Jan 24. 2019
57.12
13 Trading Days
5.14%
Link
LONG
Mar 7. 2019
69.81
Mar 27. 2019
76.78
14 Trading Days
9.99%
Link
LONG
Nov 19. 2019
58.09
Dec 9. 2019
63.54
13 Trading Days
9.39%
Link
LONG
Nov 4. 2020
47.61
Nov 19. 2020
50.47
11 Trading Days
6.01%
Link
LONG
Dec 17. 2020
51.19
Jan 5. 2021
55.47
11 Trading Days
8.35%
Link
LONG
Oct 28. 2021
31.20
Nov 10. 2021
33.40
9 Trading Days
7.04%
Link
Company Information
Stock Symbol
IONS
Exchange
NasdaqGS
Company URL
http://www.ionispharm.com
Company Phone
7609319200
CEO
Stanley T. Crooke
Headquarters
California
Business Address
2855 GAZELLE COURT, CARLSBAD, CA 92010
Sector
-
Industry Category
-
Industry Group
-
CIK
0000874015
About

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of antisense drug discovery. It operates its business through the Ionis Core and Akea Therapeutics segments. The Ionis Core segment involves a a novel drug discovery platform generate a broad pipeline of drugs. The Akea Therapeutics segment develops and commercializes drugs for cardiometabolic disorders. The company was founded by Stanley T. Crooke in January 1989 and is headquartered in Carlsbad, CA.

Description

Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The company's flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients with...

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading